Noxopharm Health Care
Biotech Cancer Healthcare

$0.043 0.002 (4.88%)

High $0.05	Low $0.04	Trades 61	Turnover $61,445	Volume 1,415,719
30 June 2023 at 4:10pm

Market Cap (15-Sep) $22,121,132 (896th)	Close (30-Jun) $0.043 0 (0%)	Volume (30-Jun) 1,415,719	Shortsold (25-Aug) 4,188 (0.00%) (598th)
52w High $0.110	52w Low $0.051	P/E -	EPS -0.01

Short Interest

ASIC data, 25 Aug 2026

% Shorted

0.00% 0.00

vs 0.00% prior report

Most Shorted Rank

598th

of 689 shorted ASX stocks

Peak Short

2.88%

Sep 2016

Days to Cover

0.1

at 50d avg vol

View full short position history →

	Subject
	NOX NOX Ann: Change of Director's Interest Notice - FB
	1 (current) 2 3
	NOX NOX Ann: Change of Director's Interest Notice - FB
	NOX NOX Ann: Change of Director's Interest Notice - BP
	NOX NOX Ann: Change of Director's Interest Notice - PM
	NOX NOX Ann: Details of Company Address
	NOX NOX Ann: IONIC Trial Abstract Published at ASCO
	NOX NOX Ann: Study results show new Sofra drug reduces inflammation
	NOX NOX Ann: Innovative Sofra research presented at European event
	NOX NOX Ann: Change of Director's Interest Notice - FB
	NOX NOX Ann: Upcoming Expiry of Listed Options (ASX Code NOXO)
	NOX NOX Ann: Change of Director's Interest Notice - FB
	NOX NOX Ann: March 2023 Quarterly Activities Report and Appendix 4C
	NOX NOX Ann: Noxopharm to Prioritise Cutting-Edge Chroma & Sofra Programs
	NOX NOX Ann: Noxopharm Announces Novel mRNA Vaccine Enhancer
	NOX NOX Ann: Appendix 4D and Half Year 2023 Financial Report
	NOX NOX Ann: Noxopharm to Present Sofra Study at LUPUS 2023 Conference
	NOX NOX Ann: December 2022 Quarterly Activities Report and Appendix 4C
	NOX NOX Ann: DARRT-2 Trial Efficacy Phase to Commence
	NOX NOX Ann: NOX Pipeline Boosted by $1.5M Grant to Hudson Institute
	NOX NOX Ann: Change of Director's Interest Notice - FB
	NOX NOX Ann: Notification of cessation of securities - NOX
	NOX NOX Ann: Federal Innovation Connections Grant Awarded
	NOX NOX Ann: IONIC Trial Progresses as Veyonda Passes Safety Milestone
	NOX NOX Ann: Notification of cessation of securities - NOX
	NOX NOX Ann: Constitution
	NOX NOX Ann: Results of Meeting
	NOX NOX Ann: Noxopharm 2022 AGM Corporate Presentation
	NOX NOX Ann: Noxopharm AGM 2022 Chair's Address
	NOX NOX Ann: CEP-2 Safety Milestone Shows Veyonda Progress
	NOX NOX Ann: Noxopharm Enhances Cash Position via R&D Rebate
	NOX NOX Ann: Change in substantial holding
	NOX NOX Ann: September 2022 Quarterly Activities Report and Appendix 4C
	NOX NOX Ann: 2022 AGM Notice of Meeting and Proxy
	NOX NOX Ann: 2022 AGM Letter to Shareholders and Proxy
	NOX NOX Ann: Unlisted Options Expiring on 21 November 2022
	NOX NOX Ann: Noxopharm 2022 Annual Report
	NOX NOX Ann: Final Director's Interest Notice - GK
	NOX NOX Ann: Resignation of Dr Graham Kelly as Non-Executive Director
	NOX NOX Ann: Novel Dual-cell Therapy Results in Pancreatic Cancer
	NOX NOX Ann: Response to ASX Price Query (Correction to ASX Ticker)
	NOX NOX Ann: Response to ASX Price Query
	NOX NOX Ann: Appendix 4E and Audited Financial Statements
	NOX NOX Ann: Appendix 4G and Corporate Governance Statement
	NOX NOX Ann: Noxopharm & UNSW Pancreatic Cancer Research at US Conference
	NOX NOX Ann: CEP-2 Trial Passes Safety Milestone
	NOX NOX Ann: DARRT-2 Trial Safety Milestone and European Site Activated
	NOX NOX Ann: June 2022 Quarterly Activities Report and Appendix 4C
	NOX NOX Ann: Mayo Clinic and Washington Uni Join Noxopharm Sarcoma Trial
	NOX NOX Ann: $1.45M Grant to Hudson Institute for Noxopharm Collaboration
	NOX NOX Ann: HIMR Collaboration Secures mRNA Vic Acceleration Fund Grant

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
15-Sep	$0.08	0	0.00 (0.00%)
14-Sep	$0.08	8,846	+0.00 (4.17%)
11-Sep	$0.07	10,000	0.00 (1.37%)
10-Sep	$0.07	13,693	0.00 (0.00%)
09-Sep	$0.07	36,817	+0.00 (4.29%)
08-Sep	$0.07	291,991	0.00 (1.41%)
07-Sep	$0.07	77,527	-0.01 (6.58%)
04-Sep	$0.08	422,485	0.00 (5.00%)
03-Sep	$0.08	7,771	0.00 (1.23%)
02-Sep	$0.08	10,824	-0.01 (8.99%)
01-Sep	$0.09	123,298	0.00 (0.00%)
31-Aug	$0.09	4,873	+0.00 (5.95%)
28-Aug	$0.08	51,074	-0.01 (6.67%)
27-Aug	$0.09	10,775	0.00 (2.17%)
26-Aug	$0.09	20,491	0.00 (3.16%)
3 up, 9 down, and 3 flat days

Noxopharm Health Care
Biotech Cancer Healthcare

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Noxopharm Health Care Biotech Cancer Healthcare

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Noxopharm Health Care
Biotech Cancer Healthcare